EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Biallelic Splicing Variant c.12479+ 3A >G in FAT4 Causes Hennekam Lymphangiectasia‐Lymphedema Syndrome 2

Selinda Mascarenhas, Yashavi Gupta, Akhil K A, Shruti Pande, Huzail Shaikh, Katta Mohan Girisha iD, Periyasamy Radhakrishnan iD, Anju Shukla

American Journal of Medical Genetics Part A · 2026-09 · 200 (9) · 2019-2024

DOI: 10.1002/ajmg.a.70166 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 16.04.2026. Verfasst von Selinda Mascarenhas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Lymphedema, Lymphangiectasis, RNA Splicing, Tumor Suppressor Proteins. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DBT-Wellcome Trust India Alliance, The Wellcome Trust DBT India Alliance, Wellcome Trust DBT India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hennekam lymphangiectasia‐lymphedema syndrome (HKLLS) is an autosomal recessive disorder, caused by biallelic variants in CCBE1 , FAT4 , and ADAMTS3 genes. We herein report a 15‐month‐old male with peripheral lymphedema, facial dysmorphism, camptodactyly and generalized hypotonia. Solo exome sequencing revealed a homozygous splice site variant, c.12479+3A>G in intron 14 of FAT4 (NM_001291303.3). Reverse transcriptase‐PCR (RT‐PCR) was performed using cDNA isolated from patient‐derived fibroblasts, which revealed aberrant splicing. This study provides a report of an additional family with a novel biallelic splice site variant in FAT4 which disrupts the normal splicing of the FAT4 mRNA, leading to aberrant splicing causing a milder form of HKLLS2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphedemaLymphangiectasisRNA SplicingTumor Suppressor ProteinsLymphangiectasis, IntestinalHumansMaleInfantAllelesMutationPedigreePhenotypeHomozygoteCraniofacial Abnormalities

Stichwörter der Autor:innen

FAT4Hennekam lymphangiectasia‐lymphedema syndrome 2lymphedema

Substanzen

Tumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
  • Department of Genetics, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
  • Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Department of Biomedicine, University of Basel, Basel, Switzerland.

ORCID-Profile: Katta Mohan Girisha, Periyasamy Radhakrishnan

Förderung

  • DBT-Wellcome Trust India Alliance
  • The Wellcome Trust DBT India Alliance
  • Wellcome Trust DBT India Alliance

Zitieren

APA

Mascarenhas, S., Gupta, Y., K A, A., Pande, S., Shaikh, H., Girisha, K. M., Radhakrishnan, P., & Shukla, A. (2026). Biallelic Splicing Variant c.12479+ 3A >G in FAT4 Causes Hennekam Lymphangiectasia‐Lymphedema Syndrome 2. American Journal of Medical Genetics Part A, 200(9), 2019-2024. https://doi.org/10.1002/ajmg.a.70166

Vancouver

Mascarenhas S, Gupta Y, K A A, Pande S, Shaikh H, Girisha KM, et al. Biallelic Splicing Variant c.12479+ 3A >G in FAT4 Causes Hennekam Lymphangiectasia‐Lymphedema Syndrome 2. American Journal of Medical Genetics Part A. 2026;200(9):2019-2024. doi:10.1002/ajmg.a.70166

BibTeX
@article{Mascarenhas2026,
  author = {Mascarenhas, Selinda and Gupta, Yashavi and K A, Akhil and Pande, Shruti and Shaikh, Huzail and Girisha, Katta Mohan and Radhakrishnan, Periyasamy and Shukla, Anju},
  title = {Biallelic Splicing Variant c.12479+ 3A >G in FAT4 Causes Hennekam Lymphangiectasia‐Lymphedema Syndrome 2},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  volume = {200},
  number = {9},
  pages = {2019--2024},
  doi = {10.1002/ajmg.a.70166}
}
Kostenlos starten →